)

Nasus Pharma (NSRX) investor relations material
Nasus Pharma Company Presentation summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Strategic positioning and technology
Focuses on powder-based intranasal drug delivery for emergency medical conditions, leveraging proprietary Nasax® technology for enhanced absorption and longer shelf-life.
Lead product NS002 targets anaphylaxis with a needle-free, convenient alternative to epinephrine autoinjectors.
Platform validated by successful Phase 3 results for intranasal naloxone (NS001), now available for partnering.
Strong intellectual property protection extends to 2038 and beyond in multiple jurisdictions.
Experienced leadership team with deep expertise in life sciences, pharma, and venture capital.
Clinical development and results
NS002 demonstrated faster and higher maximal epinephrine absorption than EpiPen in pilot and Phase 2 studies.
Phase 2: 91% of subjects reached therapeutic plasma threshold at 6 minutes with NS002 4mg, versus 55% for EpiPen.
Comparable pharmacodynamic activity to EpiPen with no serious adverse events and good tolerability.
NS001 (naloxone) delivered faster and higher absorption than Narcan in Phase 3, supporting platform efficacy.
Additional Phase 2 studies for NS002 planned for Q4 2025, pivotal and pediatric studies to follow in 2026.
Market opportunity and competitive landscape
Anaphylaxis affects 1–3% globally; US market includes 40M type 1 allergy patients and $2.3B epinephrine market.
Many at-risk patients remain untreated or do not carry/refill epinephrine, highlighting unmet need.
Needle-free epinephrine products could expand market access and address patient barriers like needle phobia and device bulk.
NS002 shows faster absorption and higher early plasma concentrations compared to other intranasal competitors.
Robust pipeline includes candidates for nausea, poisoning, seizures, and opioid overdose, supporting long-term growth.
The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage